Industry / Russia
Biotech Sector Could Learn From The US
March 2008 | Industry NewsRussia should adopt more market reforms in order to replicate some of the successes achieved by the US's biotechnology sector, according to a recent report by the Washington Legal Foundation.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
